FDA Inspection
VitalantVitalant – FDA Inspection, Aug 19, 2019
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on August 19, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 3a9b71cb-e049-49a7-b46e-ccb93a0ceabe
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1106251
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Vitalant
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 13, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 19, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 22, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 6, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 10, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1233322 - 2024-03-13
- FDA Inspection 945649 - 2015-10-19
- FDA Inspection 852226 - 2013-10-22
- FDA Inspection 756175 - 2011-12-06
- FDA Inspection 628530 - 2009-11-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.